Most Recent
Apotex threatened to infringe Cialis patents, court finds
Intellectual Property 2018-08-27 11:09 pm By Cat Fredenburgh

A judge has found two patents held by an Eli Lilly & Co. unit for erectile dysfunction drug Cialis are valid and that generic manufacturer Apotex threatened to infringe the patents.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Millennium wins injunction against Juno over generic cancer drug
Intellectual Property 2018-08-27 11:27 am By Christine Caulfield

US-based Millennium Pharmaceuticals has secured a temporary injunction that bans generic drug maker Juno Pharmaceuticals from importing or selling its cheap version of breakthrough cancer drug Velcade in Australia.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Dr. Reddy’s slams Millennium’s injunction bid in cancer drug case
Intellectual Property 2018-08-23 5:41 pm By Miklos Bolza

An urgent injunction sought by US-based Millennium Pharmaceuticals to block generic drug maker Dr Reddy’s Laboratories from launching a cheap version of the breakthrough cancer drug Velcade has been panned as unnecessary.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Guard rail maker wins ruling invalidating rival’s patent
Intellectual Property 2018-08-22 11:34 pm By Cat Fredenburgh

A maker of guard rails used on highways has won a judgment invalidating a rival’s patent, with a judge finding the patent lacks novelty.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Kraft can bring new claims against Bega mid-trial
Competition & Consumer Protection 2018-08-22 8:00 pm By Cat Fredenburgh

The long, complex battle over who owns the rights to the Kraft peanut butter trade dress just promised to get longer, with Kraft winning approval to bring fresh allegations against Bega mid-trial.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Sanofi launches patent case over Alphapharm injector pen
Intellectual Property 2018-08-21 11:00 pm By Miklos Bolza

Global pharmaceutical giant Sanofi-Aventis has launched patent infringement proceedings against generic drug maker Alphapharm seeking “urgent interlocutory relief” to prevent a generic injector pen from being listed on the market.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Apple keeps patent application for iPhone, iPad interface alive
Intellectual Property 2018-08-21 10:46 pm By Cat Fredenburgh

A patent application for a computer-implemented invention filed by Apple may have a shot at approval, with a delegate for IP Australia saying strict tests for patentability should be eschewed in favor of a more holistic approach.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Caesarstone wins trade mark fight for ‘honest concurrent use’
Intellectual Property 2018-08-17 11:52 pm By Miklos Bolza

Building products maker Caesarstone can register two trade marks despite their deceptive similarity to a mark by ceramic tile maker Ceramiche Caesar, a judge has ruled, after finding Caesarstone had shown honest concurrent use of the marks.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Judge gives RE/MAX, Resimax a week to settle trade mark fight
Intellectual Property 2018-08-17 9:37 pm By Miklos Bolza

After signalling last month they were close to resolving their trade mark dispute, real estate companies RE/MAX and Resimax have been been given one last chance — and one more week — to settle.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Patent suits launched over breakthrough cancer drug
Intellectual Property 2018-08-15 10:25 pm By Miklos Bolza

Two patent infringement lawsuits have been launched over attempts to sell generic versions of breakthrough cancer drug Velcade in Australia, after a US court last year struck down attempts to invalidate a patent for the drug.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?